Neuphoria Therapeutics Inc. (NEUP)
$3.95+1.02%Close
BUYRECOVERY · day 19
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $21M
- Avg volume
- 151.0K
- Beta
- 0.75
- P/E (TTM)
- -0.36
- Short % float
- 1.57%
- Days to cover
- 1.0
- SI change
- +327.4%
- 1W
- +2.60%
- 1M
- +8.52%
- 3M
- -27.92%
- YTD
- +3.40%
- vs SPY 1W
- +3.79%
- vs SPY 1M
- +5.20%
- vs SPY 3M
- -30.31%
- vs SPY YTD
- -8.35%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- TVRDSELLTvardi Therapeutics, Inc.CRISISQ -9$1.78-4.30%
- SUPNBUYSupernus Pharmaceuticals, Inc.RECOVERYQ 27$45.11-1.61%
- ZJYLBUYJin Medical International Ltd.CRISISQ 4$3.04+0.00%
- NRCBUYNational Research CorporationRECOVERYQ 3$21.92-1.22%
- JSPRBUYJasper Therapeutics, Inc.CRISISQ -12$0.72+0.00%
- TFXBUYTeleflex IncorporatedBULLQ 10$138.31-0.37%
- APVOBUYAptevo Therapeutics Inc.CRISISQ -28$2.41-10.07%
- GANXBUYGain Therapeutics, Inc.RECOVERYQ -12$2.00-0.50%
- ZNTLSELLZentalis Pharmaceuticals, Inc.CRISISQ -5$3.76-1.83%
- COGTSELLCogent Biosciences, Inc.BEARQ 14$36.23-1.36%
- DRTSBUYAlpha Tau Medical Ltd.BULLQ 16$14.70-1.47%
- NXTCBUYNextCure, Inc.CRISISQ -7$5.89-6.36%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 17
- VALUE
- 0
- GROWTH
- 81
- GARP
- 9
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-68.0%
REV YoY-
ROE-1.7%
EPS YoY-
ROA-81.8%
GROSS105
OP231
NET272
[VALUATION]
P/E TTM-0.36
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B0.73
P/FCF-
EV/EBITDA-0.09
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.12
ALTMAN Z-
CURR RATIO14.31
ND/EBITDA-
BETA0.75
NET INCOME (TTM) < 0
